Last reviewed · How we verify
NCT03748368
Computer-based Tutorial for the Informed Consent Process for Cataract Surgery in Turkish or Serbian Speaking Patients
NA trial testing Cataract presentation in Cataract in 72 participants. Status unknown.
1 May 2020
Quick facts
| Lead sponsor | Prim. Prof. Dr. Oliver Findl, MBA |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 72 |
| Start date | 1 January 2017 |
| Primary completion | 1 May 2020 |
| Estimated completion | 1 July 2020 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Cataract presentation
- Placebo presentation
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Who can join
Adults 21 to 105, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigate if a computer-based tutorial enhances the quality and efficiency of the informed consent process for cataract surgery in Turkish or Serbian speaking patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03748368
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Prim. Prof. Dr. Oliver Findl, MBA trials
Trials by the same sponsor.
- NCT07425626 — Brillouin Scanning in Cataractous Eyes · active not recruiting
- NCT06624826 — Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality · NA · recruiting
- NCT06459284 — Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes · completed
- NCT06948851 — New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes · active not recruiting
- NCT07436247 — Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03748368 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prim. Prof. Dr. Oliver Findl, MBA
- Last refreshed: 2 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03748368.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing